---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-26-001137"
form_type: "8-K"
ticker: "CLRO"
cik: "0000840715"
company_name: "CLEARONE INC"
filed_at: "2026-07-06T20:30:22+00:00"
generated_at: "2026-07-06T20:32:29.732940+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ClearOne to acquire Cortigent from Vivani Medical in stock deal; plans $10-15M financing

## Summary
- ClearOne (CLRO) will issue 12.5M shares to Vivani (VANI) for Cortigent, a neurostimulation firm.
- Concurrent S-1 registration to raise $10M-$15M via units of common stock and warrants.
- Post-closing board set at 5 members: Adam Mendelsohn (Chair), Jonathan Adams, John Bowers, Linda Szyper, Eric Robinson.
- Jonathan Adams to be President & CEO; Ed Sedo CFO; Rachel Evans Corporate Secretary.
- Closing conditions include stockholder approvals, financing completion, and Nasdaq continued listing; 180-day termination right.

## SEC filing metadata
- accession: 0001753926-26-001137
- form_type: 8-K
- ticker: CLRO
- cik: 0000840715
- company_name: CLEARONE INC
- filed_at: 2026-07-06T20:30:22+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/840715/000175392626001137/0001753926-26-001137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/840715/000175392626001137/clro-20260706.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-26-001137
- JSON: https://secwatch.observer/filing/0001753926-26-001137.json
- Plain text: https://secwatch.observer/filing/0001753926-26-001137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.